This target is commonly used for people on GLP-1 medications who are eating smaller portions but still need enough protein to support daily nutrition
Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al
S.SongZ
The most common side effects of GLP-1 receptor agonists are gastrointestinal symptoms including nausea, vomiting, diarrhoea, and abdominal discomfort, particularly during treatment initiation
By 2020, an estimated 2.2 billion adults worldwide were suffering from overweight and obesity, and it is predicted that this number will increase to 3.3 billion by 2035 [1]
Patients with chronic kidney disease should discuss protein targets with their healthcare provider